Pamela Wapnick - Sep 5, 2024 Form 4 Insider Report for Metagenomi, Inc. (MGX)

Role
Chief Financial Officer
Signature
/s/ Matthew L. Wein, attorney-in-fact
Stock symbol
MGX
Transactions as of
Sep 5, 2024
Transactions value $
-$18,043
Form type
4
Date filed
9/6/2024, 05:14 PM
Previous filing
Apr 3, 2024
Next filing
Dec 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGX Common Stock Sale -$18K -6.27K -9.04% $2.88 63.1K Sep 5, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.
F2 The shares were sold in multiple transactions ranging from $2.80 to $2.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shars sold at each price.